These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23313813)

  • 21. Raman spectroscopy as a process analytical technology for pharmaceutical manufacturing and bioprocessing.
    Esmonde-White KA; Cuellar M; Uerpmann C; Lenain B; Lewis IR
    Anal Bioanal Chem; 2017 Jan; 409(3):637-649. PubMed ID: 27491299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated production of plant-based vaccines and pharmaceuticals.
    Wirz H; Sauer-Budge AF; Briggs J; Sharpe A; Shu S; Sharon A
    J Lab Autom; 2012 Dec; 17(6):449-57. PubMed ID: 23015521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease.
    Streefland M; van de Waterbeemd B; Happé H; van der Pol LA; Beuvery EC; Tramper J; Martens DE
    Vaccine; 2007 Apr; 25(16):2994-3000. PubMed ID: 17313999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Process analytical technologies (PAT) in freeze-drying of parenteral products.
    Patel SM; Pikal M
    Pharm Dev Technol; 2009; 14(6):567-87. PubMed ID: 19883247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality control and analytical techniques for biopharmaceuticals.
    Robinson CJ; Jones C
    Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous downstream processing of biopharmaceuticals.
    Jungbauer A
    Trends Biotechnol; 2013 Aug; 31(8):479-92. PubMed ID: 23849674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Process Analytical Technologies - Advances in bioprocess integration and future perspectives.
    Gerzon G; Sheng Y; Kirkitadze M
    J Pharm Biomed Anal; 2022 Jan; 207():114379. PubMed ID: 34607168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemometrics-based process analytical technology (PAT) tools: applications and adaptation in pharmaceutical and biopharmaceutical industries.
    Challa S; Potumarthi R
    Appl Biochem Biotechnol; 2013 Jan; 169(1):66-76. PubMed ID: 23138336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregates in monoclonal antibody manufacturing processes.
    Vázquez-Rey M; Lang DA
    Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.
    Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S
    Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein.
    Looby M; Ibarra N; Pierce JJ; Buckley K; O'Donovan E; Heenan M; Moran E; Farid SS; Baganz F
    Biotechnol Prog; 2011; 27(6):1718-29. PubMed ID: 21948302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality control and analytical methods for baculovirus-based products.
    Roldão A; Vicente T; Peixoto C; Carrondo MJ; Alves PM
    J Invertebr Pathol; 2011 Jul; 107 Suppl():S94-105. PubMed ID: 21784235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous processing and the applications of online tools in pharmaceutical product manufacture: developments and examples.
    Ooi SM; Sarkar S; van Varenbergh G; Schoeters K; Heng PW
    Ther Deliv; 2013 Apr; 4(4):463-70. PubMed ID: 23557287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Konstantinov KB; Cooney CL
    J Pharm Sci; 2015 Mar; 104(3):813-20. PubMed ID: 25417595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review of PAT Strategies in Secondary Solid Oral Dosage Manufacturing of Small Molecules.
    Laske S; Paudel A; Scheibelhofer O;
    J Pharm Sci; 2017 Mar; 106(3):667-712. PubMed ID: 28017464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical control of process impurities in Pazopanib hydrochloride by impurity fate mapping.
    Li Y; Liu DQ; Yang S; Sudini R; McGuire MA; Bhanushali DS; Kord AS
    J Pharm Biomed Anal; 2010 Aug; 52(4):493-507. PubMed ID: 20189340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial: Can modern vaccine technology pursue the success of traditional vaccine manufacturing?
    Grabherr R; Reichl U
    Biotechnol J; 2015 May; 10(5):657-8. PubMed ID: 25943526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.